Security key
03843E104
Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST)
CUSIP: 03843E104
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 120,192,308
- Total 13F shares
- 19,076,504
- Share change
- +4,140,329
- Total reported value
- $31,486,971
- Put/Call ratio
- 2.2%
- Price per share
- $1.65
- Number of holders
- 54
- Value change
- +$6,895,297
- Number of buys
- 42
- Number of sells
- 7
Report period
Q2 2023
Institutions
54
Top holders
10
AQST full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Aquestive Therapeutics, Inc. SEC filings
Aquestive Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03843E104
Recent filing periods:
Top shareholders of AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bratton Capital Management, L.P. |
13F
|
Company |
8.2%
|
9,810,958
|
$11,184,492 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
1,310,586
|
$1,494,068 | — | 31 Mar 2023 | |
| Vahanian & Associates Financial Planning Inc. |
13F
|
Company |
0.6%
|
718,908
|
$819,555 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.43%
|
518,800
|
$591,000 | — | 31 Mar 2023 | |
| Bracebridge Capital, LLC |
13F
|
Company |
0.36%
|
428,571
|
$488,571 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
387,575
|
$441,835 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.3%
|
359,658
|
$410,010 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.25%
|
302,848
|
$345,000 | — | 31 Mar 2023 | |
| Latash Investments, LLC |
13F
|
Company |
0.2%
|
243,134
|
$277,173 | — | 31 Mar 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
142,956
|
$162,970 | — | 31 Mar 2023 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.11%
|
130,305
|
$148,000 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.1%
|
116,272
|
$132,550 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.08%
|
96,037
|
$109,482 | — | 31 Mar 2023 | |
| Kestra Advisory Services, LLC |
13F
|
Company |
0.07%
|
86,350
|
$98,439 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.05%
|
59,828
|
$68,204 | — | 31 Mar 2023 | |
| HBK Sorce Advisory LLC |
13F
|
Company |
0.04%
|
42,348
|
$48,277 | — | 31 Mar 2023 | |
| Financial Advocates Investment Management |
13F
|
Company |
0.02%
|
25,000
|
$28,500 | — | 31 Mar 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
23,430
|
$26,710 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.02%
|
23,100
|
$26,334 | — | 31 Mar 2023 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.02%
|
19,230
|
$22,115 | — | 31 Mar 2023 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.01%
|
15,542
|
$17,718 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.01%
|
14,853
|
$16,932 | — | 31 Mar 2023 | |
| Virtu Financial LLC |
13F
|
Company |
0.01%
|
12,884
|
$15,000 | — | 31 Mar 2023 | |
| D.B. Root & Company, LLC |
13F
|
Company |
0.01%
|
12,500
|
$14,250 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
11,381
|
$12,974 | — | 31 Mar 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
9,211
|
$11,000 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
4,670
|
$5,324 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
3,744
|
$4,268 | — | 31 Mar 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
2,000
|
$2,280 | — | 31 Mar 2023 | |
| Richard W. Paul & Associates, LLC |
13F
|
Company |
0%
|
1,423
|
$1,622 | — | 31 Mar 2023 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
1,176
|
$1,000 | — | 31 Mar 2023 | |
| TCI Wealth Advisors, Inc. |
13F
|
Company |
0%
|
500
|
$570 | — | 31 Mar 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
267
|
$304 | — | 31 Mar 2023 | |
| NewSquare Capital LLC |
13F
|
Company |
0%
|
130
|
$148 | — | 31 Mar 2023 | |
| James S. Scibetta |
3/4/5
|
Director |
—
mixed-class rows
|
51,635
mixed-class rows
|
$25,624 | — | 15 Jun 2021 | |
| Keith J. Kendall |
3/4/5
|
CEO and President, Director |
—
class O/S missing
|
375,000
|
— | — | 10 Mar 2022 | |
| Kenneth Truitt |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
100,000
|
— | — | 06 Sep 2022 | |
| Theresa Wood |
3/4/5
|
SVP-HR and Org. Development |
—
class O/S missing
|
70,000
|
— | — | 10 Mar 2022 | |
| Nancy Lurker |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 15 Jun 2021 |
Institutional Holders of Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) as of Q2 2023
As of 30 Jun 2023,
Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,076,504 shares.
The largest 10 holders included
Bratton Capital Management, L.P., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, ARMISTICE CAPITAL, LLC, Vahanian & Associates Financial Planning Inc., Bracebridge Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., Walleye Capital LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
54
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
34
Q2 2023 holders
54
Holder diff
20
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.